Literature DB >> 9302086

Regulation of GABA(A) receptor subunit mRNA expression by the pesticide dieldrin in embryonic brainstem cultures: a quantitative, competitive reverse transcription-polymerase chain reaction study.

J Liu1, A L Morrow, L L Devaud, D R Grayson, J M Lauder.   

Abstract

Cyclodiene organochlorine pesticides, such as dieldrin, inhibit gamma-aminobutyric acid (GABA)ergic neurotransmission by blocking the Cl- channel of GABA(A) receptors. This action may make the developing nervous system especially vulnerable to these neurotoxins, which could interfere with the trophic actions of GABA on developing neurons and alter expression of GABA(A) receptors. We have used an in vitro model to determine whether exposure to dieldrin alters developmental expression of GABA(A) receptor subunit mRNA transcripts. Dissociated cell cultures were prepared from embryonic day 14 (E14) brainstem and cultured in serum-containing medium for 1 day in vitro (DIV), then treated for 2 DIV with 10 microM dieldrin in serum-free medium. This dose was based on preliminary experiments and previous studies (Nagata et al.: Brain Res 645:19-26, 1994; Pomes et al.: J Pharmacol Exp Ther 271:1616-1623, 1994). Absolute amounts of alpha1, beta3, gamma1, gamma2S and gamma2L mRNA transcripts were quantified in these cultures by quantitative, competitive reverse transcription-polymerase chain reaction (RT-PCR) using subunit-selective internal standards. The most abundant GABA(A) subunit transcript was beta3, which was much more highly expressed than gamma2S, gamma1, gamma2L, or alpha1 subunit mRNAs. Dieldrin differentially regulated expression of these transcripts. Levels of beta3 subunit transcripts were significantly increased (by 300%) by dieldrin, whereas expression of gamma2S and gamma2L transcripts were decreased (by 50% and 40%, respectively). However, dieldrin did not alter the ratio of gamma2S to gamma2L transcripts, indicating that it did not affect alternative splicing of gamma2 transcripts. Dieldrin appeared to increase expression of alpha1 subunit transcripts, but this effect was not statistically significant. Dieldrin did not significantly alter expression of gamma1 subunit transcripts. These results support the hypothesis that in utero exposure to cyclodiene pesticides could pose a risk to the developing brain by virtue of their ability to alter gene expression of GABA(A) receptor subunits, which could produce GABA(A) receptors with altered functional properties.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9302086     DOI: 10.1002/(SICI)1097-4547(19970901)49:5<645::AID-JNR15>3.0.CO;2-U

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  5 in total

1.  Perinatal heptachlor exposure increases expression of presynaptic dopaminergic markers in mouse striatum.

Authors:  W Michael Caudle; Jason R Richardson; Minzheng Wang; Gary W Miller
Journal:  Neurotoxicology       Date:  2005-08       Impact factor: 4.294

2.  Developmental heptachlor exposure increases susceptibility of dopamine neurons to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)in a gender-specific manner.

Authors:  Jason R Richardson; W Michael Caudle; Min Zheng Wang; E Danielle Dean; Kurt D Pennell; Gary W Miller
Journal:  Neurotoxicology       Date:  2008-06-05       Impact factor: 4.294

3.  A developmental shift from GABAergic to glycinergic transmission in the central auditory system.

Authors:  V C Kotak; S Korada; I R Schwartz; D H Sanes
Journal:  J Neurosci       Date:  1998-06-15       Impact factor: 6.167

Review 4.  Aldrin and dieldrin: a review of research on their production, environmental deposition and fate, bioaccumulation, toxicology, and epidemiology in the United States.

Authors:  J L Jorgenson
Journal:  Environ Health Perspect       Date:  2001-03       Impact factor: 9.031

Review 5.  Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models.

Authors:  D Rice; S Barone
Journal:  Environ Health Perspect       Date:  2000-06       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.